InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by UNITED BIOMEDICAL INC. Director active across 1 companies, notably Vaxxinity, Inc.. Aggregated, 6 reports have been published. Total volume traded: €300k. The latest transaction was disclosed on 16 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€188,957100,000 shares@ €1.88960.18% mcap62.9% of flow
Class A common stock
SEC:0000899243-22-023409:0·
Ideal exit: 13 Mar 2023 (T+270)
€27,55610,000 shares@ €2.75560.026% mcap9.2% of flow
Class A common stock
SEC:0000899243-22-021996:0·
Ideal exit: 5 Mar 2023 (T+270)
€58,69018,105 shares@ €3.24170.054% mcap19.5% of flow
Class A common stock
SEC:0000899243-22-015866:0·
Ideal exit: 21 Jan 2023 (T+270)
€25,2688,038 shares@ €3.14360.023% mcap8.4% of flow
Class A common stock
SEC:0000899243-22-015802:0·
Ideal exit: 20 Jan 2023 (T+270)
247,050 shares
Class A common stock
SEC:0000899243-21-044658·
247,050 shares
Class A common stock
SEC:0000899243-21-044658:0·
6 of 6 declarations
About UNITED BIOMEDICAL INC
Director at Vaxxinity, Inc.
